ArticleCancers2022

HER2-Targeted Antibody-Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget's Disease Models: In Vivo and Immunohistochemical Analyses.

Keiko Tokuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.